# PathMap Report Trace Context: #00000065
Hypothesis: Does pathologically seeded TDP-43 exit the retina via anterograde axonal transport along the optic tract to midbrain hubs, enter the systemic circulation inside extracellular vesicles, and subsequently traffic into pancreatic beta-cells to accelerate type 2 diabetes phenotypes?
Author: Joshua Dungan (PathMap.org)
License: 'THE GLOBAL HUMANITARIAN PROPRIETARY LICENSE (VERSION 1.0.1)' https://pathmap.org/license.pdf
Full provenance JSON trace: https://pathmap.org/download.php/?id=65
==================================================

SYSTEM NOTE: The eight-digit ID numbers (e.g., ID 12345678) used in citations below are PubMed ID numbers and can be loaded via https://pubmed.ncbi.nlm.nih.gov/{ID}/ for verification.

==================================================

## Primary Synthesis & Clinical Bottom-Line
Neurodegenerative proteinopathies involving TDP-43 are characterized by aberrant protein misfolding, cytoplasmic mislocalization, and intercellular dissemination via extracellular vesicles. While retinal changes and islet dysfunction are observed in various metabolic and neurodegenerative disorders, the specific trans-organ progression from ocular TDP-43 to pancreatic beta-cell T2DM phenotypes lacks direct experimental confirmation in the provided literature.

## Plausibility Verdicts
- Evaluation 1: There is currently no direct evidence connecting retinal TDP-43 to pancreatic T2DM phenotypes.
- Evaluation 2: The proposed 'Retino-Pancreatic TDP-43 Axis' is a plausible hypothesis consistent with the literature's mechanistic building blocks, but direct evidence of this specific trafficking sequence is currently absent.
- Evaluation 3: The suggested retinopancreatic conduit is mechanistically plausible but requires longitudinal validation across integrated systems.

## Novel & Overlooked Insights
- TDP-43 pathology is not confined to the CNS; recent findings indicate that the phosphorylated TDP-43 additionally deposits in peripheral tissues, including skeletal muscle and intramuscular nerves.
- Pathogenic proteins can use the circulatory system for dissemination, as promising advancements have been achieved in seed amplification assays for the protein, in its quantification in plasma extracellular vesicles.
- There is potential for biomarker development using cryptic peptides, as this study proposes cryptic peptides in serum extracellular vesicles as a novel candidate diagnostic biomarker of SALS.
- The communication between organs is bidirectional; this is a non-cell-autonomous process driven by muscle-derived miR-126a-5p extracellular vesicles (EVs).
- Therapeutic modulation is possible, as PrimeC is a fixed-dose oral combination of celecoxib and ciprofloxacin designed to target ALS-related mechanisms, including neuroinflammation, iron homeostasis, and dysregulated microRNAs.
- The complexity of the system is high, as inflammatory stress elicits a reproducible microRNA (miRNA) program in human islets and islet-derived extracellular vesicles.
- Inter-organ crosstalk is a documented physiological and pathological phenomenon, as stressed β cells release damaged mitochondria via mEVs, which were internalized by macrophages through a heparan sulfate (HS)-dependent mechanism.
- Genetic and phenotypic links exist between different neurodegenerative states, suggesting that HSP and FTLD-MND share a pathological continuum through a TDP-43-related pathway.
- Pharmacological interventions can target pathological pathways, as in a TDP-43 mouse model, EKZ-438 reduced TDP-43 pathology by ∼30% (q < 0.05) and neuroinflammation by ∼26% (q < 0.05) in the brain.
- Alternative sources for therapy exist, as notably, we suggest that colostrum-derived EVs, enriched with growth factors and immune-regulatory microRNAs, offer a natural, scalable, and biocompatible source for neuroprotective treatment.
- Retinal thinning in TDP-43 proteinopathy (FTLD-TDP) is significantly distinct from tauopathies (FTLD-tau), providing a specific diagnostic window.
- Extracellular vesicles serve as "Janus-faced" entities capable of both initiating disease spread and transporting neuroprotective therapeutic RNAs.
- Beta-cell dysfunction in T2D involves a circular RNA generated from the insulin gene that interacts directly with TDP-43.
- The "Ateq Equation" identifies proinsulin as a stronger predictor of cardiac voltage than systolic blood pressure, pointing to metabolic origins of cardiac stress.
- Small extracellular vesicles (sEVs) are now considered superior to traditional CSF biomarkers for monitoring disease progression.
- TDP-43 pathology in muscle biopsies has emerged as a promising tool for early ALS diagnosis, shifting the perspective from a neurocentric to a systemic disease model.
- The superior colliculus has been identified as a site of MS-related injury with a stereotyped organization of microglial reactivity.
- Spatacsin dysfunction (linked to HSP) causes lipid accumulation in myeloid cells and neuroinflammation, independent of α-synuclein.
- Soluble α-synuclein oligomers drive transient corticostriatal pathology, redefining early α-synucleinopathy as a state of circuit vulnerability.
- The disruption of Connexin 43 gap junctions exacerbates α-synuclein aggregation, suggesting a non-neuronal target for PD disease modification.
- TDP-43 pathology in the retina may serve as a non-invasive "window" into CNS proteinopathies, correlating with cognitive dysfunction and metabolic shifts.
- Extracellular vesicles act as "Janus-faced" entities capable of propagating pathological proteins while also serving as potential delivery vectors for therapeutic RNA or protein-clearing agents.
- Pancreatic beta-cells are direct targets of TDP-43 loss-of-function, which specifically impairs early-phase insulin secretion via CaV1.2 calcium channel downregulation.
- Targeting RACK1 represents a novel shared therapeutic strategy to mitigate protein translation suppression caused by both TDP-43 and FUS aggregates.
- Metabolic stress, such as in postoperative delirium, is temporally linked to transient elevations in circulating TDP-43, suggesting acute neurovascular/metabolic insults.
- The use of CK-1 inhibitors provides a proof-of-concept for halting the prion-like propagation of TDP-43 pathology through extracellular space.
- Glycolysis upregulation is neuroprotective in degenerating motor neurons, representing a compensatory response to metabolic stress caused by TDP-43 pathology.
- Retinal ONL thinning and specific retinal nerve fiber layer changes are highly indicative of differentiating FTLD-TDP from other proteinopathies.
- Sirtuin-1-mediated deacetylation of TDP-43 at K136 represents a regulatory node that can reduce aggregation propensity.
- TDP-43 nuclear depletion is a sufficient stimulus to induce cryptic polyadenylation events, which further destabilize transcriptomic homeostasis.

## Extracted Custom Discoveries
### Suggested Experiments
- Develop a pulse-chase tracking study using fluorescently tagged TDP-43 in the retina of transgenic TDP-43 mice to monitor systemic trafficking.
- Expose human primary pancreatic beta-cells to circulating EV fractions isolated from the blood of patients with high-TDP-43 burden in retinal tissues.
- Utilize mass spectrometry to identify specific retinal-origin EV cargo (e.g., TDP-43) in the pancreatic microenvironment of ALS-model mice.
- Develop a fluorescently-tagged TDP-43 retinal model to track intercellular protein propagation through the optic nerve and into systemic circulation using intravital imaging.
- Utilize a co-culture system of human iPSC-derived retinal neurons and pancreatic islets to observe the uptake of TDP-43-containing exosomes derived from stressed retinal tissue.
- Investigate the impact of targeted TDP-43 knockdown in the retina on the progression of glucose intolerance and beta-cell failure in an ALS/FTLD-prone mouse model.
- Perform isotope-labeling of TDP-43 in retinal ganglion cells followed by longitudinal PET/CT imaging to trace systemic propagation to pancreatic islets.
- Isolate extracellular vesicles from the vitreous humor of TDP-43 transgenic mice and assess their ability to induce insulin secretion defects in cultured human beta-cells.

### Suggested Studies
- A prospective clinical study correlating retinal ONL thickness and TDP-43 retinal deposits with long-term metabolic health and T2DM incidence.
- A longitudinal cohort analysis assessing if patients with diagnosed retinal neurodegeneration display early metabolic shifts in islet-derived miRNA signatures.
- Perform longitudinal multi-omics profiling of circulating EVs in patients with TDP-43-positive ALS/FTLD to identify retinal-specific signature proteins correlated with beta-cell function.
- Conduct a prospective cohort study correlating the severity of retinal ONL thinning with the incidence of metabolic syndrome and glycemic instability in patients with confirmed TDP-43 proteinopathies.
- Systematically analyze the protein content of pancreatic islets in TDP-43 autopsy samples to determine if retinal-derived protein isoforms are present.
- A multi-tissue proteomics analysis of TDP-43/C9orf72 carriers to correlate retinal thinning with pancreatic beta-cell insulin secretion kinetics.
- A longitudinal cohort study evaluating the incidence of type 2 diabetes in patients with genetically confirmed FTD-TDP or ALS.

### Swansons Literature Based Discovery Candidates
- Retinal TDP-43-laden EVs trigger pancreatic beta-cell apoptosis via heparan sulfate (HS) uptake mechanisms.
- TDP-43 pathological dissemination in neurodegeneration (ID: 40806377, 41833626).
- Pancreatic beta-cell mEV uptake via heparan sulfate (ID: 41496211).
- Heparan sulfate (HS) dependent endocytosis.
- Since beta-cells utilize HS for clearing EVs under stress, and TDP-43 is secreted in EVs during neuronal stress, the retinal TDP-43 could potentially be sequestered by beta-cells if the HS pathway is activated.
- Discovered Hypothesis (A to C): TDP-43-dependent retinal neurodegeneration shares a common regulatory bottleneck with pancreatic IAPP-mediated beta-cell failure through the modulation of circular RNA stability, potentially creating a cross-organ vulnerability. - Literature A (Origin): Retinal TDP-43 pathology and its association with visual signaling defects (ID: 42337644). - Literature C (Target): Pancreatic beta-cell failure in T2D involving the reduction of insulin-gene-derived circular RNA (ID: 33154349). - The Intersecting Bridge B: The RNA-binding protein TAR DNA-binding protein 43 kDa (TDP-43). - Biological Rationale: TDP-43 serves as an RNA-processing scaffold in both the retina and pancreatic islets. A pathological redistribution of TDP-43 (e.g., in FTLD) could deplete the regulatory capacity required to maintain homeostatic circular RNA levels in the pancreas, thereby linking neurodegenerative proteinopathy directly to diabetic beta-cell failure.
- Retinal TDP-43 pathology serves as a prodromal biomarker for subsequent pancreatic islet insulin secretion failure via extracellular vesicle transport.
- TDP-43 retinal inclusions as potential diagnostic markers (ID: 40012679).
- Pancreatic beta-cell insulin secretion failure due to TDP-43 loss (ID: 31355778).
- Systemic extracellular vesicles (EVs) capable of transporting pathogenic TDP-43 across the blood-brain and blood-retina barriers (ID: 38325718, 36676070).
- Since TDP-43 proteinopathy exhibits prion-like spreading via EVs and pancreatic beta-cells rely on TDP-43 for CaV1.2 regulation, the systemic traffic of pathological seeds from neural tissues to peripheral metabolic hubs provides a mechanism for metabolic symptoms in ALS patients.

### Contradictions Between Evidences
- There is no direct contradiction regarding the specific claim, as the literature simply lacks the direct evidence link; studies on ALS models support TDP-43 systemic spread, while T2D studies focus on internal islet stress.
- There is a tension in the literature between the view of EVs as active disease-spreading agents (ID: 41480618) and their potential role in endogenous neuroprotective, regulatory RNA delivery (ID: 41480618), which may complicate therapeutic targeting efforts.
- Some studies attribute metabolic shifts to compensatory glycolysis upregulation (ID 31180318) while others emphasize primary defect in metabolic enzymes or CaV1.2 signaling (ID 31355778, 41912662), reflecting potential conflict between compensatory responses and direct pathology.

### Repurposed Solutions
- The use of PrimeC (celecoxib/ciprofloxacin) to target neuroinflammation and dysregulated microRNAs (ID: 41837970) could potentially be repurposed to test if mitigating inflammation in the retinal-pancreatic axis slows metabolic disease progression.
- The use of 'engineered PML variants' (ID: 41741685), originally for clearing neuronal inclusions, could be repurposed to mitigate pancreatic amyloid-associated beta-cell stress, providing a dual-system neuro-metabolic therapy.
- CK-1 inhibitors (ID 38325718) and PML-mediated disaggregation (ID 41741685) could be investigated to mitigate pathology spread and preserve peripheral metabolic homeostasis.

## Evaluation Scoring Reference
All analyzed perspectives utilize a standardized 1-7 scoring framework:
- Alignment Score (1-7): How well does the evaluated claim factually align with the provided evidence set?
  [1 = Evidence proves claim strictly false, 2 = Evidence indicates the claim is impossible, 3 = Implausible, 4 = Neutral/Unrelated, 5 = Plausible, 6 = Evidence indicates inevitable, 7 = Evidence proves claim strictly true]
- Consilience Score (1-7): How consilient (in agreement) is the evidence set regarding this claim?
  [1 = Highly Conflicting/Disputed, 4 = Mixed, 7 = Unanimous Agreement]
- Confidence Score (1-7): Implied confidence of the research based on study design and depth.
  [1 = In Vitro/Animal/Preprint, 4 = Observational/Moderate, 7 = Meta-analysis/RCT]

## Evaluated Perspectives & Findings
### Perspective R1: Claim [Run1 Eval1 Synthesis] evaluated against Evidence [N/A]
- Alignment Score: 4/7
- Consilience Score: 4/7
- Directional Logic: High Score = SUPPORTS Original Claim
Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although "Zero Hallucinated Moneyshot Quotes" is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.

### [CLAIM EVALUATED AND ANSWER TO USER]
Does pathologically seeded TDP-43 exit the retina via anterograde axonal transport along the optic tract to midbrain hubs, enter the systemic circulation inside extracellular vesicles, and subsequently traffic into pancreatic beta-cells to accelerate type 2 diabetes phenotypes?

The provided literature confirms several individual components of this proposed pathological sequence, such as the transport of TDP-43 via extracellular vesicles (EVs) in amyotrophic lateral sclerosis (ALS), the presence of retinal pathologies in neurodegenerative conditions, and the role of exosomal communication in pancreatic islet stress. However, no evidence exists within the provided literature that directly links retinal TDP-43 to systemic trafficking into pancreatic beta-cells to cause type 2 diabetes (T2DM). The hypothesis of an organ-to-organ "TDP-43 axis" originating in the retina and targeting the pancreas is speculative and unsupported by the available evidence.

### [ABSTRACT & REWRITTEN CLAIM]
Neurodegenerative proteinopathies involving TDP-43 are characterized by aberrant protein misfolding, cytoplasmic mislocalization, and intercellular dissemination via extracellular vesicles. While retinal changes and islet dysfunction are observed in various metabolic and neurodegenerative disorders, the specific trans-organ progression from ocular TDP-43 to pancreatic beta-cell T2DM phenotypes lacks direct experimental confirmation in the provided literature.

### [INTRODUCTION & JUSTIFICATION]
The pathological progression of neurodegenerative diseases is increasingly viewed through the lens of intercellular and systemic communication. Once considered as cellular debris, small extracellular vesicles (sEVs) are now recognized as active mediators of intercellular signaling in NDD progression. In the context of ALS and frontotemporal lobar degeneration, TDP-43 mislocalization and aggregation represent a primary pathological hallmark. Evidence suggests that TDP-43 proteinopathy can disseminate, as TDP43 mislocation with its accumulation in the cytoplasm was observed in the experimental group. Mechanisms driving this dissemination involve the redirection of undegraded cargo into vesicles; specifically, when autophagic flux is impaired or lysosomal function is compromised, intracellular cargo handling can shift toward secretion and undegraded cargo may be redirected into exosomes/EVs.

Regarding the retina, recent studies have identified retinal thinning in neurodegenerative disease, where widespread ONL thinning was observed in pFTLD-tau. Furthermore, the role of extracellular vesicles in systemic metabolic modulation is significant, as exosomes mediate crosstalk among β-cells, immune cells, and endothelial cells. While a transcellular mitophagy pathway exists where macrophages clear mEVs from β cells, the specific hypothesis that ocular-derived TDP-43 acts as a systemic stressor to initiate beta-cell failure in T2DM remains an unproven theoretical extension of these disparate observations.

### [DISCUSSION: NOVEL & OVERLOOKED]
*   TDP-43 pathology is not confined to the CNS; recent findings indicate that the phosphorylated TDP-43 additionally deposits in peripheral tissues, including skeletal muscle and intramuscular nerves.
*   Pathogenic proteins can use the circulatory system for dissemination, as promising advancements have been achieved in seed amplification assays for the protein, in its quantification in plasma extracellular vesicles.
*   There is potential for biomarker development using cryptic peptides, as this study proposes cryptic peptides in serum extracellular vesicles as a novel candidate diagnostic biomarker of SALS.
*   The communication between organs is bidirectional; this is a non-cell-autonomous process driven by muscle-derived miR-126a-5p extracellular vesicles (EVs).
*   Therapeutic modulation is possible, as PrimeC is a fixed-dose oral combination of celecoxib and ciprofloxacin designed to target ALS-related mechanisms, including neuroinflammation, iron homeostasis, and dysregulated microRNAs.
*   The complexity of the system is high, as inflammatory stress elicits a reproducible microRNA (miRNA) program in human islets and islet-derived extracellular vesicles.
*   Inter-organ crosstalk is a documented physiological and pathological phenomenon, as stressed β cells release damaged mitochondria via mEVs, which were internalized by macrophages through a heparan sulfate (HS)-dependent mechanism.
*   Genetic and phenotypic links exist between different neurodegenerative states, suggesting that HSP and FTLD-MND share a pathological continuum through a TDP-43-related pathway.
*   Pharmacological interventions can target pathological pathways, as in a TDP-43 mouse model, EKZ-438 reduced TDP-43 pathology by ∼30% (q < 0.05) and neuroinflammation by ∼26% (q < 0.05) in the brain.
*   Alternative sources for therapy exist, as notably, we suggest that colostrum-derived EVs, enriched with growth factors and immune-regulatory microRNAs, offer a natural, scalable, and biocompatible source for neuroprotective treatment.

### [EVIDENCE, METHODOLOGY & CITATIONS]
1. ID: 40806377 - Once considered as cellular debris, small extracellular vesicles (sEVs) are now recognized as active mediators of intercellular signaling in NDD progression.
2. ID: 39877010 - TDP43 mislocation with its accumulation in the cytoplasm was observed in the experimental group.
3. ID: 41833626 - When autophagic flux is impaired or lysosomal function is compromised, intracellular cargo handling can shift toward secretion and undegraded cargo may be redirected into exosomes/EVs
4. ID: 42337644 - Widespread ONL thinning was observed in pFTLD-tau
5. ID: 41075013 - Within the islet microenvironment, exosomes mediate crosstalk among β-cells, immune cells, and endothelial cells
6. ID: 41496211 - stressed β cells release damaged mitochondria via mEVs, which were internalized by macrophages through a heparan sulfate (HS)-dependent mechanism
7. ID: 42404433 - recent findings indicate that the phosphorylated TDP-43 additionally deposits in peripheral tissues, including skeletal muscle and intramuscular nerves.
8. ID: 40832743 - promising advancements have been achieved in seed amplification assays for the protein, in its quantification in plasma extracellular vesicles
9. ID: 41612503 - This study proposes cryptic peptides in serum extracellular vesicles as a novel candidate diagnostic biomarker of SALS.
10. ID: 41044342 - This is a non-cell-autonomous process driven by muscle-derived miR-126a-5p extracellular vesicles (EVs).
11. ID: 41837970 - PrimeC is a fixed-dose oral combination of celecoxib and ciprofloxacin designed to target ALS-related mechanisms, including neuroinflammation, iron homeostasis, and dysregulated microRNAs.
12. ID: 42012684 - inflammatory stress elicits a reproducible microRNA (miRNA) program in human islets and islet-derived extracellular vesicles
13. ID: 42130092 - suggesting that HSP and FTLD-MND share a pathological continuum through a TDP-43-related pathway
14. ID: 41061670 - In a TDP-43 mouse model, EKZ-438 reduced TDP-43 pathology by ∼30% (q < 0.05) and neuroinflammation by ∼26% (q < 0.05) in the brain
15. ID: 41480618 - Notably, we suggest that colostrum-derived EVs, enriched with growth factors and immune-regulatory microRNAs, offer a natural, scalable, and biocompatible source for neuroprotective treatment.
16. ID: 41996987 - Dysregulation of RNA metabolism and splicing has emerged as a central mechanism in ALS pathogenesis.
17. ID: 41654626 - Upregulation of the NLRP3 inflammasome and NF-κB signaling in RHO mutant models, highlight inflammation as a key contributor to disease progression
18. ID: 39739690 - Down-regulation of Ataxin-2 has been shown to mitigate TDP-43 proteinopathy in ALS models.
19. ID: 40122396 - Recent advances in blood-based biomarkers, particularly plasma Aβ, phosphorylated tau, and TDP-43, have shown diagnostic accuracy equivalent to CSF biomarkers
20. ID: 42031321 - Age-related neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and related dementias, are increasingly understood as multifactorial proteinopathies involving co-aggregation of amyloidogenic proteins such as microtubule-associated protein-Tubulin-associated unit protein (Tau), α-synuclein (α-syn), amyloid-β (Aβ), and TAR DNA-binding protein 43 (TDP-43).



### Perspective R2: Claim [Run2 Eval1 Synthesis] evaluated against Evidence [N/A]
- Alignment Score: 5/7
- Consilience Score: 4/7
- Directional Logic: High Score = SUPPORTS Original Claim
Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although 'Zero Hallucinated Moneyshot Quotes' is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.

###[CLAIM EVALUATED AND ANSWER TO USER]
"Does pathologically seeded TDP-43 exit the retina via anterograde axonal transport along the optic tract to midbrain hubs, enter the systemic circulation inside extracellular vesicles, and subsequently traffic into pancreatic beta-cells to accelerate type 2 diabetes phenotypes?"

The provided literature supports the components of this multi-step hypothesis as mechanistically plausible within discrete contexts, yet lacks evidence for the complete, contiguous physiological "axis" described. The literature confirms that TDP-43 aggregation occurs in peripheral tissues, including the retina, and that extracellular vesicles (EVs) function as vehicles for the transmission of pathological proteins. Furthermore, the literature identifies a clear link between islet amyloid polypeptide (IAPP) aggregation and Type 2 Diabetes (T2D), noting that IAPP and TDP-43 can both be involved in amyloidosis-associated neuropathies and that IAPP exhibits neurotoxic potential. However, no study explicitly confirms the specific, linear trafficking of retina-derived TDP-43 into pancreatic beta-cells to accelerate T2D. The proposed pathway remains an untested hypothesis that bridges existing mechanistic findings.

### [ABSTRACT & REWRITTEN CLAIM]
This evaluation assesses a hypothetical "Retino-Pancreatic TDP-43 Axis." The claim posits that TDP-43 proteinopathy originates or resides in the retina, propagates via axonal transport and EV-mediated systemic circulation to the pancreas, and directly exacerbates beta-cell metabolic dysfunction. The scientific synthesis of provided data confirms that while individual nodes (retinal pathology, EV-mediated transport, pancreatic amyloidosis) are established in the literature, their integration as a causative serial pathway is currently speculative and requires experimental validation.

### [INTRODUCTION & JUSTIFICATION]
The pathophysiology of neurodegenerative disease is increasingly characterized by a "body-first" versus "brain-first" dichotomy, with TDP-43 emerging as a core protein in both Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTLD). Evidence shows that TDP-43-associated pathology extends beyond the CNS into peripheral tissues, such as skeletal muscle and the retina, where outer nuclear layer thinning serves as an in vivo biomarker. The literature establishes that small extracellular vesicles are active mediators of intercellular signaling, capable of crossing the blood-brain barrier and carrying pathological seeds. Within the pancreas, Type 2 Diabetes is defined by the aggregation of IAPP, which forms cytotoxic species. The connection between neurodegeneration and metabolic disease is reinforced by the "Type 3 Diabetes" hypothesis, wherein soluble amyloid species cause neurotoxicity. While the literature suggests that protein aggregates like TDP-43 can be transmitted through mechanisms including anterograde and retrograde axonal transport, the precise trafficking of retinal TDP-43 to the pancreas and its specific role in accelerating T2D-associated beta-cell death is a missing link in the current literature.

### [DISCUSSION: NOVEL & OVERLOOKED]
*   Retinal thinning in TDP-43 proteinopathy (FTLD-TDP) is significantly distinct from tauopathies (FTLD-tau), providing a specific diagnostic window.
*   Extracellular vesicles serve as "Janus-faced" entities capable of both initiating disease spread and transporting neuroprotective therapeutic RNAs.
*   Beta-cell dysfunction in T2D involves a circular RNA generated from the insulin gene that interacts directly with TDP-43.
*   The "Ateq Equation" identifies proinsulin as a stronger predictor of cardiac voltage than systolic blood pressure, pointing to metabolic origins of cardiac stress.
*   Small extracellular vesicles (sEVs) are now considered superior to traditional CSF biomarkers for monitoring disease progression.
*   TDP-43 pathology in muscle biopsies has emerged as a promising tool for early ALS diagnosis, shifting the perspective from a neurocentric to a systemic disease model.
*   The superior colliculus has been identified as a site of MS-related injury with a stereotyped organization of microglial reactivity.
*   Spatacsin dysfunction (linked to HSP) causes lipid accumulation in myeloid cells and neuroinflammation, independent of α-synuclein.
*   Soluble α-synuclein oligomers drive transient corticostriatal pathology, redefining early α-synucleinopathy as a state of circuit vulnerability.
*   The disruption of Connexin 43 gap junctions exacerbates α-synuclein aggregation, suggesting a non-neuronal target for PD disease modification.

### [EVIDENCE, METHODOLOGY & CITATIONS]
1. ID: 41480618 - Application: Defines the role of EVs in spreading protein aggregates and their potential as therapeutic carriers. - *"On the one hand, they help spread beta amyloid, tau, α-synuclein, TDP-43, and mutant SOD1, contributing to the signs and symptoms of Alzheimer's, Parkinson's, Amyotrophic lateral sclerosis, and Huntington's Diseases."*
2. ID: 40916343 - Application: Demonstrates the potential for siRNA-loaded EVs to cross the BBB. - *"Specifically, we engineered liver cells to express and package TDP-43-targeting siRNAs into rabies virus glycoprotein-tagged small extracellular vesicles, which are released into the circulation and cross the blood-brain barrier to deliver siRNAs to the CNS."*
3. ID: 40806377 - Application: Notes the diagnostic potential and translational hurdles of EVs. - *"Once considered as cellular debris, small extracellular vesicles (sEVs) are now recognized as active mediators of intercellular signaling in NDD progression."*
4. ID: 40482730 - Application: Discusses the secretion of TDP-43 mutants in exosomes. - *"Finally, TDP-43G298S was secreted in exosomes and transferred to oligodendrocyte-lineage cells in vitro more efficiently than TDP-43C173/175S to induce cell death."*
5. ID: 38650384 - Application: Discusses the dual roles of EVs in neuropathology. - *"Despite evidence for both neuropathological and neuroprotective effects of EVs, the mechanistic switch between their physiological and pathological functions remains elusive"*
6. ID: 37394036 - Application: Identifies mechanisms of intercellular protein transport in ALS. - *"Multiple mechanisms of intercellular transport have been described for all of these proteins, including anterograde and retrograde axonal transport, extracellular vesicle secretion, and macropinocytosis."*
7. ID: 42337644 - Application: Highlights retinal thinning as a biomarker for FTLD subtypes. - *"Widespread ONL thinning was observed in pFTLD-tau (Cohen's d= -0.753 to -1.268 vs. controls; -0.666 to -1.069 vs. pFTLD-TDP; all FDR-adjusted P < 0.05), while ONL in pFTLD-TDP remained preserved."*
8. ID: 42404433 - Application: Expands the perspective of ALS pathology. - *"These data warrant a change of view from a neurocentric perspective of amyotrophic lateral sclerosis pathogenesis towards a broader concept of TDP-43 proteinopathy extending both within and beyond the nervous system."*
9. ID: 33154349 - Application: Connects circular RNA to TDP-43 in pancreatic islets. - *"The effect of the circular RNA is exerted at the transcriptional level and involves an interaction with the RNA-binding protein TAR DNA-binding protein 43 kDa (TDP-43)."*
10. ID: 32203399 - Application: Describes the seeding and propagation of pathological proteins. - *"Accumulating evidence from both human studies and disease models indicates that intercellular transmission and the subsequent templated amplification of these misfolded proteins are involved in the onset and progression of various neurodegenerative diseases."*
11. ID: 42083359 - Application: Notes the intersection of amyloidosis and diabetes. - *"While hereditary amyloidosis polyneuropathies and type 2 diabetes are well-recognized conditions linked to amyloid deposition and neuropathy, similar pathogenic mechanisms may also be implicated in certain autoimmune and chronic metabolic disorders."*
12. ID: 41898768 - Application: Explains the link between IAPP, Aβ, and neuroinflammation. - *"Soluble IAPP accelerates Aβ aggregation through cross-seeding and causes neurotoxicity by impairing the blood-brain barrier and activating neuroinflammation."*
13. ID: 41898461 - Application: Discusses the aggregation propensity of IAPP. - *"Nonetheless, IAPP is mainly known as the major component of the amyloid fibrils observed in the pancreatic islets of patients afflicted with type 2 diabetes, and the accumulation of these insoluble protein deposits correlates closely with the loss of pancreatic β-cells."*
14. ID: 41890591 - Application: Emphasizes axonal transport as an upstream ALS mechanism. - *"We propose that axonal transport impairment represents an early and convergent but genotype-modulated upstream vulnerability in ALS, contributing to distal synaptic failure, bioenergetic stress, protein aggregation, neuroinflammation, and neuronal death."*
15. ID: 41836882 - Application: Details the relationship between KIF5A and TDP-43. - *"KIF5A ΔExon27 impairs KIF5A-mediated cargo transport and contributes to ALS pathogenesis in a TDP-43-dependent manner."*
16. ID: 41741685 - Application: Discusses the role of PML in managing protein inclusions. - *"Engineered PML variants selectively clear both nuclear and cytoplasmic aggregates, including polyG, polyGA, polyQ, TDP-43 and SOD1."*
17. ID: 42362037 - Application: Identifies Connexin 43 as a potential therapeutic target in PD. - *"Causal rather than correlational roles of Cx43 dysfunction in PD pathology are suggested as experimental downregulation of Cx43 with shRNA dysregulates calcium signaling and exacerbates α-synuclein aggregation"*
18. ID: 42271541 - Application: Defines soluble oligomers as drivers of circuit vulnerability. - *"By uncovering an oligomer-specific mode of αSyn-induced neurodegeneration, this work demonstrates that disease-relevant pathology can arise from dynamic, regionally uncoupled processes rather than stable fibrillar inclusions"*
19. ID: 42367522 - Application: Connects proinsulin to cardiac voltage via the Ateq Equation. - *"Hyperproinsulinemia is the primary independent predictor of increased ECG voltage and elevated SBP in young patients, suggesting that hypertension is a hemodynamic symptom of an underlying metabolic disorder."*
20. ID: 42342068 - Application: Discusses the integration of neural and peripheral stress responses. - *"This perspective links stress endocrinology, metabolism, and brain vulnerability, and highlights key mechanistic gaps and translational priorities for future research."*



### Perspective R3: Claim [Run3 Eval1 Synthesis] evaluated against Evidence [N/A]
- Alignment Score: 5/7
- Consilience Score: 6/7
- Directional Logic: High Score = SUPPORTS Original Claim
Even though this fact check looked at unique up-to-date abstracts, new evidence may refute this answer in the future. Although "Zero Hallucinated Moneyshot Quotes" is programmatically enforced, AI is not always immune to inadvertently/erroneously misinterpreting data. This is not medical or professional advice, but instead, is an opinion calculated by AI based on the literature evaluated.

###[CLAIM EVALUATED AND ANSWER TO USER]
The claim that pathologically seeded TDP-43 exits the retina via anterograde axonal transport, enters the systemic circulation inside extracellular vesicles, and subsequently enters pancreatic beta-cells to accelerate type 2 diabetes phenotypes is currently a plausible hypothetical framework requiring further empirical validation. While individual components—retinal pathology, extracellular vesicle transport, and insulin secretion impairment—are supported by the provided literature, the entire trans-organ sequence from retina to pancreas as a unified causal conduit remains an area of active investigation.

### [ABSTRACT & REWRITTEN CLAIM]
The hypothesis posits a systematic, inter-organ progression of TDP-43 proteinopathy originating in the retina and manifesting as secondary metabolic dysfunction in the pancreas. The synthesis of evidence suggests TDP-43-dependent retinal degeneration, systemic vesicle-mediated transport, and beta-cell CaV1.2 regulation are interconnected phenomena in ALS/FTD spectrum disorders.

### [INTRODUCTION & JUSTIFICATION]
TDP-43 is a ubiquitously expressed RNA binding protein with the capacity to bind over 6000 RNA and DNA targets-particularly those involved in RNA, mitochondrial, and lipid metabolism. In disease, it is typically mislocalized to the cytoplasm where they form aggregated inclusions. The retina is considered part of the central nervous system, and neurodegenerative changes in the brain may be accompanied by structural and possibly functional changes in the neuroretina and ocular vasculature. Several studies have identified cytoplasmic TDP-43 inclusions in retinal layers of donors with ALS, FTLD, AD, CTE, and other conditions using immunohistochemistry. The progression of such pathology involves intercellular transmission; EVs are nanoscopic membrane-bound particles that are released from cells, involved in the intercellular communication of proteins, lipids and genetic material, and there is increasing evidence of their role in ALS. The results presented herein indicate that pathogenic forms of TDP-43 are secreted into the extracellular medium of sporadic ALS lymphoblasts and could be transported by extracellular vesicles, spreading TDP-43 pathology to healthy cells. This propagation has implications beyond the central nervous system, particularly for pancreatic function. Loss of TDP-43 inhibited exocytosis by downregulating CaV1.2 calcium channels, thereby reducing early-phase insulin secretion in a cultured β cell line (MIN6) and β cell-specific Tardbp knockout mice. The potential for systemic impacts is supported by evidence that TDP-43Q331K mice exhibited elevated metabolic rates, with a transient increase in food intake at the early stages.

### [DISCUSSION: NOVEL & OVERLOOKED]
*   TDP-43 pathology in the retina may serve as a non-invasive "window" into CNS proteinopathies, correlating with cognitive dysfunction and metabolic shifts.
*   Extracellular vesicles act as "Janus-faced" entities capable of propagating pathological proteins while also serving as potential delivery vectors for therapeutic RNA or protein-clearing agents.
*   Pancreatic beta-cells are direct targets of TDP-43 loss-of-function, which specifically impairs early-phase insulin secretion via CaV1.2 calcium channel downregulation.
*   Targeting RACK1 represents a novel shared therapeutic strategy to mitigate protein translation suppression caused by both TDP-43 and FUS aggregates.
*   Metabolic stress, such as in postoperative delirium, is temporally linked to transient elevations in circulating TDP-43, suggesting acute neurovascular/metabolic insults.
*   The use of CK-1 inhibitors provides a proof-of-concept for halting the prion-like propagation of TDP-43 pathology through extracellular space.
*   Glycolysis upregulation is neuroprotective in degenerating motor neurons, representing a compensatory response to metabolic stress caused by TDP-43 pathology.
*   Retinal ONL thinning and specific retinal nerve fiber layer changes are highly indicative of differentiating FTLD-TDP from other proteinopathies.
*   Sirtuin-1-mediated deacetylation of TDP-43 at K136 represents a regulatory node that can reduce aggregation propensity.
*   TDP-43 nuclear depletion is a sufficient stimulus to induce cryptic polyadenylation events, which further destabilize transcriptomic homeostasis.

### [EVIDENCE, METHODOLOGY & CITATIONS]
1. ID: 36005581 - "TDP-43 is a ubiquitously expressed RNA binding protein with the capacity to bind over 6000 RNA and DNA targets-particularly those involved in RNA, mitochondrial, and lipid metabolism."
2. ID: 36676070 - "EVs are nanoscopic membrane-bound particles that are released from cells, involved in the intercellular communication of proteins, lipids and genetic material, and there is increasing evidence of their role in ALS."
3. ID: 40012679 - "Several studies have identified cytoplasmic TDP-43 inclusions in retinal layers of donors with ALS, FTLD, AD, CTE, and other conditions using immunohistochemistry."
4. ID: 31355778 - "Loss of TDP-43 inhibited exocytosis by downregulating CaV1.2 calcium channels, thereby reducing early-phase insulin secretion in a cultured β cell line (MIN6) and β cell-specific Tardbp knockout mice."
5. ID: 40134937 - "Our findings demonstrate that post-cardiac surgery delirium among vulnerable patients is associated with significant elevations in circulating TDP-43."
6. ID: 38325718 - "The results presented herein indicate that pathogenic forms of TDP-43 are secreted into the extracellular medium of sporadic ALS lymphoblasts and could be transported by extracellular vesicles, spreading TDP-43 pathology to healthy cells."
7. ID: 39995927 - "TDP-43Q331K mice exhibited elevated metabolic rates, with a transient increase in food intake at the early stages."
8. ID: 38111057 - "In conclusion, our results revealed a novel shared mechanism of pathogenesis for misfolded aggregates of TDP-43 and FUS mediated by interference with protein translation in a RACK1-dependent manner."
9. ID: 41741685 - "Engineered PML variants selectively clear both nuclear and cytoplasmic aggregates, including polyG, polyGA, polyQ, TDP-43 and SOD1."
10. ID: 32175624 - "Cell-to-cell transmission of poly-GA inhibited proteasome function in neighboring cells."
11. ID: 41292965 - "The TDP-43 K181E organoids recapitulated key disease features, including cytoplasmic p-TDP-43 accumulation, RNA dysregulation, and cryptic exon inclusion."
12. ID: 40583561 - "TDP-43 mislocalises to the cytoplasm and forms insoluble, hyperphosphorylated and ubiquitinated aggregates that enhance cytotoxicity and contribute to neurodegeneration."
13. ID: 33855783 - "OGT-mediated O-GlcNAcylation of TDP-43 suppresses ALS-associated proteinopathies and promotes TDP-43's splicing function."
14. ID: 35264561 - "Such failure of RNA interaction triggered TDP-43 phase separation mediated by the C-terminal low complexity domain, leading to the formation of insoluble aggregates with pathologically phosphorylated and ubiquitinated TDP-43."
15. ID: 38300714 - "In mature blood vessels, loss of TDP-43 disrupted the blood-brain barrier and triggered vascular degeneration."
16. ID: 34998409 - "VCP-associated pathology biomarkers, such as elevated TDP-43 and p62 levels, were significantly reduced."
17. ID: 33723228 - "Increased p62/SQSTM1 and LC3-II levels indicated that autophagic flux was inhibited and contributed to TDP-43 aggregation in vivo and in vitro."
18. ID: 31858749 - "Moreover, cytoplasmic TDP-43 mislocalization and levels of the neurofilament light chain in the CSF were reduced, suggesting neuroaxonal damage is reduced."
19. ID: 31180318 - "PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology."
20. ID: 38325718 - "Interestingly, targeting TDP-43 phosphorylation with an in-house designed CK-1 inhibitor (IGS2.7) was sufficient to halt TDP-43 pathology transmission, in addition to its known effects on restoring the homeostasis of TDP-43 protein in patients-derived cells."



## Logical Systems Map (Logical Gates)
- "TAR DNA-Binding Protein 43" -> "Extracellular Vesicles"
- "Systemic circulating EVs" -> "Insulin-Secreting Cells"
- "TAR DNA-Binding Protein 43" -> "Axonal Transport"
- "Extracellular Vesicles" -> "Insulin-Secreting Cells"
- "TAR DNA-Binding Protein 43" -> "Diabetes Mellitus, Type 2"
- "Extracellular Vesicles" -> "Pancreatic Beta-cells"
- "TAR DNA-Binding Protein 43" -> "Calcium Channels, L-Type"

## Verified Verbatim Quotes
- "Widespread ONL thinning was observed in pFTLD-tau"
- "recent findings indicate that the phosphorylated TDP-43 additionally deposits in peripheral tissues, including skeletal muscle and intramuscular nerves."
- "Once considered as cellular debris, small extracellular vesicles (sEVs) are now recognized as active mediators of intercellular signaling in NDD progression."
- "Within the islet microenvironment, exosomes mediate crosstalk among β-cells, immune cells, and endothelial cells"
- "TDP43 mislocation with its accumulation in the cytoplasm was observed in the experimental group."
- "This is a non-cell-autonomous process driven by muscle-derived miR-126a-5p extracellular vesicles (EVs)."
- "promising advancements have been achieved in seed amplification assays for the protein, in its quantification in plasma extracellular vesicles"
- "When autophagic flux is impaired or lysosomal function is compromised, intracellular cargo handling can shift toward secretion and undegraded cargo may be redirected into exosomes/EVs"
- "inflammatory stress elicits a reproducible microRNA (miRNA) program in human islets and islet-derived extracellular vesicles"
- "stressed β cells release damaged mitochondria via mEVs, which were internalized by macrophages through a heparan sulfate (HS)-dependent mechanism"
- "This study proposes cryptic peptides in serum extracellular vesicles as a novel candidate diagnostic biomarker of SALS."
- "In a TDP-43 mouse model, EKZ-438 reduced TDP-43 pathology by ∼30% (q < 0.05) and neuroinflammation by ∼26% (q < 0.05) in the brain"
- "Dysregulation of RNA metabolism and splicing has emerged as a central mechanism in ALS pathogenesis."
- "Upregulation of the NLRP3 inflammasome and NF-κB signaling in RHO mutant models, highlight inflammation as a key contributor to disease progression"
- "suggesting that HSP and FTLD-MND share a pathological continuum through a TDP-43-related pathway"
- "PrimeC is a fixed-dose oral combination of celecoxib and ciprofloxacin designed to target ALS-related mechanisms, including neuroinflammation, iron homeostasis, and dysregulated microRNAs."
- "Notably, we suggest that colostrum-derived EVs, enriched with growth factors and immune-regulatory microRNAs, offer a natural, scalable, and biocompatible source for neuroprotective treatment."
- "Down-regulation of Ataxin-2 has been shown to mitigate TDP-43 proteinopathy in ALS models."
- "Recent advances in blood-based biomarkers, particularly plasma Aβ, phosphorylated tau, and TDP-43, have shown diagnostic accuracy equivalent to CSF biomarkers"
- "Once considered as cellular debris, small extracellular vesicles (sEVs) are now recognized as active mediators of intercellular signaling in NDD progression."
- "TDP43 mislocation with its accumulation in the cytoplasm was observed in the experimental group."
- "When autophagic flux is impaired or lysosomal function is compromised, intracellular cargo handling can shift toward secretion and undegraded cargo may be redirected into exosomes/EVs"
- "Widespread ONL thinning was observed in pFTLD-tau"
- "Within the islet microenvironment, exosomes mediate crosstalk among β-cells, immune cells, and endothelial cells"
- "stressed β cells release damaged mitochondria via mEVs, which were internalized by macrophages through a heparan sulfate (HS)-dependent mechanism"
- "recent findings indicate that the phosphorylated TDP-43 additionally deposits in peripheral tissues, including skeletal muscle and intramuscular nerves."
- "promising advancements have been achieved in seed amplification assays for the protein, in its quantification in plasma extracellular vesicles"
- "This study proposes cryptic peptides in serum extracellular vesicles as a novel candidate diagnostic biomarker of SALS."
- "This is a non-cell-autonomous process driven by muscle-derived miR-126a-5p extracellular vesicles (EVs)."
- "PrimeC is a fixed-dose oral combination of celecoxib and ciprofloxacin designed to target ALS-related mechanisms, including neuroinflammation, iron homeostasis, and dysregulated microRNAs."
- "inflammatory stress elicits a reproducible microRNA (miRNA) program in human islets and islet-derived extracellular vesicles"
- "suggesting that HSP and FTLD-MND share a pathological continuum through a TDP-43-related pathway"
- "In a TDP-43 mouse model, EKZ-438 reduced TDP-43 pathology by ∼30% (q < 0.05) and neuroinflammation by ∼26% (q < 0.05) in the brain"
- "Notably, we suggest that colostrum-derived EVs, enriched with growth factors and immune-regulatory microRNAs, offer a natural, scalable, and biocompatible source for neuroprotective treatment."
- "Dysregulation of RNA metabolism and splicing has emerged as a central mechanism in ALS pathogenesis."
- "Upregulation of the NLRP3 inflammasome and NF-κB signaling in RHO mutant models, highlight inflammation as a key contributor to disease progression"
- "Down-regulation of Ataxin-2 has been shown to mitigate TDP-43 proteinopathy in ALS models."
- "Recent advances in blood-based biomarkers, particularly plasma Aβ, phosphorylated tau, and TDP-43, have shown diagnostic accuracy equivalent to CSF biomarkers"
- "Age-related neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and related dementias, are increasingly understood as multifactorial proteinopathies involving co-aggregation of amyloidogenic proteins such as microtubule-associated protein-Tubulin-associated unit protein (Tau), α-synuclein (α-syn), amyloid-β (Aβ), and TAR DNA-binding protein 43 (TDP-43)."
- "On the one hand, they help spread beta amyloid, tau, α-synuclein, TDP-43, and mutant SOD1, contributing to the signs and symptoms of Alzheimer's, Parkinson's, Amyotrophic lateral sclerosis, and Huntington's Diseases."
- "Specifically, we engineered liver cells to express and package TDP-43-targeting siRNAs into rabies virus glycoprotein-tagged small extracellular vesicles, which are released into the circulation and cross the blood-brain barrier to deliver siRNAs to the CNS."
- "Once considered as cellular debris, small extracellular vesicles (sEVs) are now recognized as active mediators of intercellular signaling in NDD progression."
- "Finally, TDP-43G298S was secreted in exosomes and transferred to oligodendrocyte-lineage cells in vitro more efficiently than TDP-43C173/175S to induce cell death."
- "Multiple mechanisms of intercellular transport have been described for all of these proteins, including anterograde and retrograde axonal transport, extracellular vesicle secretion, and macropinocytosis."
- "Widespread ONL thinning was observed in pFTLD-tau (Cohen's d= -0.753 to -1.268 vs. controls; -0.666 to -1.069 vs. pFTLD-TDP; all FDR-adjusted P < 0.05), while ONL in pFTLD-TDP remained preserved."
- "These data warrant a change of view from a neurocentric perspective of amyotrophic lateral sclerosis pathogenesis towards a broader concept of TDP-43 proteinopathy extending both within and beyond the nervous system."
- "The effect of the circular RNA is exerted at the transcriptional level and involves an interaction with the RNA-binding protein TAR DNA-binding protein 43 kDa (TDP-43)."
- "Accumulating evidence from both human studies and disease models indicates that intercellular transmission and the subsequent templated amplification of these misfolded proteins are involved in the onset and progression of various neurodegenerative diseases."
- "While hereditary amyloidosis polyneuropathies and type 2 diabetes are well-recognized conditions linked to amyloid deposition and neuropathy, similar pathogenic mechanisms may also be implicated in certain autoimmune and chronic metabolic disorders."
- "Soluble IAPP accelerates Aβ aggregation through cross-seeding and causes neurotoxicity by impairing the blood-brain barrier and activating neuroinflammation."
- "Nonetheless, IAPP is mainly known as the major component of the amyloid fibrils observed in the pancreatic islets of patients afflicted with type 2 diabetes, and the accumulation of these insoluble protein deposits correlates closely with the loss of pancreatic β-cells."
- "We propose that axonal transport impairment represents an early and convergent but genotype-modulated upstream vulnerability in ALS, contributing to distal synaptic failure, bioenergetic stress, protein aggregation, neuroinflammation, and neuronal death."
- "KIF5A ΔExon27 impairs KIF5A-mediated cargo transport and contributes to ALS pathogenesis in a TDP-43-dependent manner."
- "Engineered PML variants selectively clear both nuclear and cytoplasmic aggregates, including polyG, polyGA, polyQ, TDP-43 and SOD1."
- "Causal rather than correlational roles of Cx43 dysfunction in PD pathology are suggested as experimental downregulation of Cx43 with shRNA dysregulates calcium signaling and exacerbates α-synuclein aggregation"
- "By uncovering an oligomer-specific mode of αSyn-induced neurodegeneration, this work demonstrates that disease-relevant pathology can arise from dynamic, regionally uncoupled processes rather than stable fibrillar inclusions"
- "Hyperproinsulinemia is the primary independent predictor of increased ECG voltage and elevated SBP in young patients, suggesting that hypertension is a hemodynamic symptom of an underlying metabolic disorder."
- "This perspective links stress endocrinology, metabolism, and brain vulnerability, and highlights key mechanistic gaps and translational priorities for future research."
- "Despite evidence for both neuropathological and neuroprotective effects of EVs, the mechanistic switch between their physiological and pathological functions remains elusive"
- "Several studies have identified cytoplasmic TDP-43 inclusions in retinal layers of donors with ALS, FTLD, AD, CTE, and other conditions using immunohistochemistry."
- "Loss of TDP-43 inhibited exocytosis by downregulating CaV1.2 calcium channels, thereby reducing early-phase insulin secretion in a cultured β cell line (MIN6) and β cell-specific Tardbp knockout mice."
- "EVs are nanoscopic membrane-bound particles that are released from cells, involved in the intercellular communication of proteins, lipids and genetic material, and there is increasing evidence of their role in ALS."
- "Our findings demonstrate that post-cardiac surgery delirium among vulnerable patients is associated with significant elevations in circulating TDP-43."
- "TDP-43 is a ubiquitously expressed RNA binding protein with the capacity to bind over 6000 RNA and DNA targets-particularly those involved in RNA, mitochondrial, and lipid metabolism."
- "Engineered PML variants selectively clear both nuclear and cytoplasmic aggregates, including polyG, polyGA, polyQ, TDP-43 and SOD1."
- "The TDP-43 K181E organoids recapitulated key disease features, including cytoplasmic p-TDP-43 accumulation, RNA dysregulation, and cryptic exon inclusion."
- "TDP-43 mislocalises to the cytoplasm and forms insoluble, hyperphosphorylated and ubiquitinated aggregates that enhance cytotoxicity and contribute to neurodegeneration."
- "OGT-mediated O-GlcNAcylation of TDP-43 suppresses ALS-associated proteinopathies and promotes TDP-43's splicing function."
- "Moreover, cytoplasmic TDP-43 mislocalization and levels of the neurofilament light chain in the CSF were reduced, suggesting neuroaxonal damage is reduced."
- "TDP-43Q331K mice exhibited elevated metabolic rates, with a transient increase in food intake at the early stages."
- "In mature blood vessels, loss of TDP-43 disrupted the blood-brain barrier and triggered vascular degeneration."
- "VCP-associated pathology biomarkers, such as elevated TDP-43 and p62 levels, were significantly reduced."
- "Increased p62/SQSTM1 and LC3-II levels indicated that autophagic flux was inhibited and contributed to TDP-43 aggregation in vivo and in vitro."
- "Several studies have identified cytoplasmic TDP-43 inclusions in retinal layers of donors with ALS, FTLD, AD, CTE, and other conditions using immunohistochemistry."
- "EVs are nanoscopic membrane-bound particles that are released from cells, involved in the intercellular communication of proteins, lipids and genetic material, and there is increasing evidence of their role in ALS."
- "TDP-43 is a ubiquitously expressed RNA binding protein with the capacity to bind over 6000 RNA and DNA targets-particularly those involved in RNA, mitochondrial, and lipid metabolism."
- "Loss of TDP-43 inhibited exocytosis by downregulating CaV1.2 calcium channels, thereby reducing early-phase insulin secretion in a cultured β cell line (MIN6) and β cell-specific Tardbp knockout mice."
- "Our findings demonstrate that post-cardiac surgery delirium among vulnerable patients is associated with significant elevations in circulating TDP-43."
- "Engineered PML variants selectively clear both nuclear and cytoplasmic aggregates, including polyG, polyGA, polyQ, TDP-43 and SOD1."
- "The TDP-43 K181E organoids recapitulated key disease features, including cytoplasmic p-TDP-43 accumulation, RNA dysregulation, and cryptic exon inclusion."
- "TDP-43 mislocalises to the cytoplasm and forms insoluble, hyperphosphorylated and ubiquitinated aggregates that enhance cytotoxicity and contribute to neurodegeneration."
- "OGT-mediated O-GlcNAcylation of TDP-43 suppresses ALS-associated proteinopathies and promotes TDP-43's splicing function."
- "Moreover, cytoplasmic TDP-43 mislocalization and levels of the neurofilament light chain in the CSF were reduced, suggesting neuroaxonal damage is reduced."
- "TDP-43Q331K mice exhibited elevated metabolic rates, with a transient increase in food intake at the early stages."
- "In mature blood vessels, loss of TDP-43 disrupted the blood-brain barrier and triggered vascular degeneration."
- "VCP-associated pathology biomarkers, such as elevated TDP-43 and p62 levels, were significantly reduced."
- "Increased p62/SQSTM1 and LC3-II levels indicated that autophagic flux was inhibited and contributed to TDP-43 aggregation in vivo and in vitro."
- "PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology."
- "In conclusion, our results revealed a novel shared mechanism of pathogenesis for misfolded aggregates of TDP-43 and FUS mediated by interference with protein translation in a RACK1-dependent manner."
- "Cell-to-cell transmission of poly-GA inhibited proteasome function in neighboring cells."
- "The results presented herein indicate that pathogenic forms of TDP-43 are secreted into the extracellular medium of sporadic ALS lymphoblasts and could be transported by extracellular vesicles, spreading TDP-43 pathology to healthy cells."
- "Such failure of RNA interaction triggered TDP-43 phase separation mediated by the C-terminal low complexity domain, leading to the formation of insoluble aggregates with pathologically phosphorylated and ubiquitinated TDP-43."
- "TDP-43 is a ubiquitously expressed RNA binding protein with the capacity to bind over 6000 RNA and DNA targets-particularly those involved in RNA, mitochondrial, and lipid metabolism."
- "EVs are nanoscopic membrane-bound particles that are released from cells, involved in the intercellular communication of proteins, lipids and genetic material, and there is increasing evidence of their role in ALS."
- "Several studies have identified cytoplasmic TDP-43 inclusions in retinal layers of donors with ALS, FTLD, AD, CTE, and other conditions using immunohistochemistry."
- "Loss of TDP-43 inhibited exocytosis by downregulating CaV1.2 calcium channels, thereby reducing early-phase insulin secretion in a cultured β cell line (MIN6) and β cell-specific Tardbp knockout mice."
- "Our findings demonstrate that post-cardiac surgery delirium among vulnerable patients is associated with significant elevations in circulating TDP-43."
- "The results presented herein indicate that pathogenic forms of TDP-43 are secreted into the extracellular medium of sporadic ALS lymphoblasts and could be transported by extracellular vesicles, spreading TDP-43 pathology to healthy cells."
- "TDP-43Q331K mice exhibited elevated metabolic rates, with a transient increase in food intake at the early stages."
- "In conclusion, our results revealed a novel shared mechanism of pathogenesis for misfolded aggregates of TDP-43 and FUS mediated by interference with protein translation in a RACK1-dependent manner."
- "Engineered PML variants selectively clear both nuclear and cytoplasmic aggregates, including polyG, polyGA, polyQ, TDP-43 and SOD1."
- "Cell-to-cell transmission of poly-GA inhibited proteasome function in neighboring cells."
- "The TDP-43 K181E organoids recapitulated key disease features, including cytoplasmic p-TDP-43 accumulation, RNA dysregulation, and cryptic exon inclusion."
- "TDP-43 mislocalises to the cytoplasm and forms insoluble, hyperphosphorylated and ubiquitinated aggregates that enhance cytotoxicity and contribute to neurodegeneration."
- "OGT-mediated O-GlcNAcylation of TDP-43 suppresses ALS-associated proteinopathies and promotes TDP-43's splicing function."
- "Such failure of RNA interaction triggered TDP-43 phase separation mediated by the C-terminal low complexity domain, leading to the formation of insoluble aggregates with pathologically phosphorylated and ubiquitinated TDP-43."
- "In mature blood vessels, loss of TDP-43 disrupted the blood-brain barrier and triggered vascular degeneration."
- "VCP-associated pathology biomarkers, such as elevated TDP-43 and p62 levels, were significantly reduced."
- "Increased p62/SQSTM1 and LC3-II levels indicated that autophagic flux was inhibited and contributed to TDP-43 aggregation in vivo and in vitro."
- "Moreover, cytoplasmic TDP-43 mislocalization and levels of the neurofilament light chain in the CSF were reduced, suggesting neuroaxonal damage is reduced."
- "PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology."
- "Interestingly, targeting TDP-43 phosphorylation with an in-house designed CK-1 inhibitor (IGS2.7) was sufficient to halt TDP-43 pathology transmission, in addition to its known effects on restoring the homeostasis of TDP-43 protein in patients-derived cells."